Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catharina Boehme

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Plos Neglected Tropical Diseases|August 19, 2021
Diagnostic testing holds the key to NTD eliminationCatharina Boehme, Sergio Carmona, Sarah Nogaro, et al.
Journal of Medical Economics|April 8, 2020
Application of a simple point-of-care test to reduce UK healthcare costs and adverse events in outpatient acute respiratory infectionsJohn E Schneider, Catharina Boehme, Bettina Borisch, et al.
Journal of Clinical Microbiology|January 29, 2011
Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF systemDoris Hillemann, Sabine Rüsch-Gerdes, Catharina Boehme, et al.
Journal of Clinical Microbiology|May 20, 2011
Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis?Viral Vadwai, Catharina Boehme, Pamela Nabeta, et al.
BMJ Global Health|June 8, 2017
Addressing the challenges of diagnostics demand and supply: insights from an online global health discussion platformNora Engel, Keri Wachter, Madhukar Pai, et al.
Plos One|November 21, 2012
Evaluation of genotype MTBDRsl assay to detect drug resistance associated with fluoroquinolones, aminoglycosides and ethambutol on clinical sedimentsKanchan Ajbani, Chaitali Nikam, Mubin Kazi, et al.
Journal of Clinical Microbiology|August 20, 2010
Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settingsPadmapriya P Banada, Satheesh K Sivasubramani, Robert Blakemore, et al.
Plos Neglected Tropical Diseases|March 3, 2016
Eliminating the Neglected Tropical Diseases: Translational Science and New TechnologiesPeter J Hotez, Bernard Pecoul, Suman Rijal, et al.
Plos One|March 25, 2017
Comparative accuracy of the REBA MTB MDR and Hain MTBDRplus line probe assays for the detection of multidrug-resistant tuberculosis: A multicenter, non-inferiority studyJoshua Havumaki, Doris Hillemann, Nazir Ismail, et al.
Plos One|February 7, 2015
Catching the missing million: experiences in enhancing TB & DR-TB detection by providing upfront Xpert MTB/RIF testing for people living with HIV in IndiaNeeraj Raizada, Kuldeep Singh Sachdeva, Achuthan Sreenivas, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Plos Neglected Tropical Diseases|August 19, 2021
Diagnostic testing holds the key to NTD eliminationCatharina Boehme, Sergio Carmona, Sarah Nogaro, et al.
Journal of Medical Economics|April 8, 2020
Application of a simple point-of-care test to reduce UK healthcare costs and adverse events in outpatient acute respiratory infectionsJohn E Schneider, Catharina Boehme, Bettina Borisch, et al.
Journal of Clinical Microbiology|January 29, 2011
Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF systemDoris Hillemann, Sabine Rüsch-Gerdes, Catharina Boehme, et al.
Journal of Clinical Microbiology|May 20, 2011
Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis?Viral Vadwai, Catharina Boehme, Pamela Nabeta, et al.
BMJ Global Health|June 8, 2017
Addressing the challenges of diagnostics demand and supply: insights from an online global health discussion platformNora Engel, Keri Wachter, Madhukar Pai, et al.
Plos One|November 21, 2012
Evaluation of genotype MTBDRsl assay to detect drug resistance associated with fluoroquinolones, aminoglycosides and ethambutol on clinical sedimentsKanchan Ajbani, Chaitali Nikam, Mubin Kazi, et al.
Journal of Clinical Microbiology|August 20, 2010
Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settingsPadmapriya P Banada, Satheesh K Sivasubramani, Robert Blakemore, et al.
Plos Neglected Tropical Diseases|March 3, 2016
Eliminating the Neglected Tropical Diseases: Translational Science and New TechnologiesPeter J Hotez, Bernard Pecoul, Suman Rijal, et al.
Plos One|March 25, 2017
Comparative accuracy of the REBA MTB MDR and Hain MTBDRplus line probe assays for the detection of multidrug-resistant tuberculosis: A multicenter, non-inferiority studyJoshua Havumaki, Doris Hillemann, Nazir Ismail, et al.
Plos One|February 7, 2015
Catching the missing million: experiences in enhancing TB & DR-TB detection by providing upfront Xpert MTB/RIF testing for people living with HIV in IndiaNeeraj Raizada, Kuldeep Singh Sachdeva, Achuthan Sreenivas, et al.
Pageof 4